Erin Quirk
Net worth: 348 000 $ as of 2024-04-29
Profile
Dr. Erin Quirk was previously employed as a President, Head-Research & Development by Terns Pharmaceuticals, Inc. and a Vice President-HIV Clinical Research by Gilead Sciences, Inc. She received her undergraduate degree from Drew University and a doctorate degree from The University of Colorado School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-22 | 75,000 ( 0.12% ) | 348 000 $ | 2024-04-29 |
Former positions of Erin Quirk
| Companies | Position | End |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Chief Executive Officer | 2024-02-06 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2018-08-31 |
Training of Erin Quirk
| Drew University | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
96
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
- Stock Market
- Insiders
- Erin Quirk
